P681 Ustekinumab therapy induced clinically meaningful improvement and remission as measured by the Inflammatory Bowel Disease Questionnaire: Results from the phase 3 UNIFI induction and maintenance studies
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.